Mohammed El-Khateeb Selected Research

Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)

1/2020

Insulin Sensitivity Indices in Patients with Polycystic Ovary Syndrome with Different Body Mass Index Categories.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammed El-Khateeb Research Topics

Disease

3	Hypertension (High Blood Pressure) 01/2022 - 07/2014
3	Diabetes Complications 01/2021 - 07/2014
2	Type 2 Diabetes Mellitus (MODY) 06/2021 - 07/2014
2	Insulin Resistance 01/2021 - 01/2020
2	Obesity 01/2020 - 01/2019
2	Diabetes Mellitus 01/2020 - 07/2013
2	Hypertriglyceridemia 01/2018 - 01/2010
2	Overweight 08/2011 - 01/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2011 - 07/2007
1	Hypophosphatemia 06/2022
1	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2021
1	Hyperglycemia 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Prediabetic State (Prediabetes) 01/2021
1	Osteoporosis 08/2020
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Hypercholesterolemia 01/2018
1	Vitamin D Deficiency 11/2015
1	Cysts 01/2014
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 01/2014
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2014
1	Neoplasms (Cancer) 12/2013
1	Breast Neoplasms (Breast Cancer) 12/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2010
1	Dyslipidemias (Dyslipidemia) 01/2010
1	Venous Thromboembolism 10/2007
1	Abdominal Obesity 07/2007
1	Inflammation (Inflammations) 03/2006
1	Hereditary Autoinflammatory Diseases 03/2006
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2005
1	Hypothyroidism 04/2003

Drug/Important Bio-Agent (IBA)

3	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2010
3	HDL CholesterolIBA 01/2020 - 07/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2022 - 07/2014
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2021
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 06/2022
1	ThiazidesIBA 06/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Sorbitol (Yal)FDA Link 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Aldehyde Reductase (Aldose Reductase)IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Growth Hormone (Somatotropin)IBA 08/2020
1	Anti-Mullerian HormoneIBA 01/2020
1	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2019
1	oxidized low density lipoproteinIBA 01/2018
1	Vitamin D-Binding ProteinIBA 11/2015
1	MagnesiumIBA 07/2014
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2014
1	Vitamin B Complex (B Vitamins)IBA 01/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2014
1	Nucleotide AptamersIBA 12/2013
1	AcetyltransferasesIBA 07/2013
1	hydroxide ionIBA 04/2011
1	25-hydroxyvitamin DIBA 04/2011
1	CholesterolIBA 01/2010
1	Prothrombin (Factor II)IBA 10/2007
1	factor V LeidenIBA 10/2007
1	Adenosine Triphosphate (ATP)IBA 07/2007
1	AutoantibodiesIBA 03/2006
1	AntigensIBA 03/2006
1	Colchicine FDA LinkGeneric 06/2005
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2003

Therapy/Procedure

2	Glycemic Control 06/2022 - 07/2014
2	Therapeutics 07/2014 - 04/2003
1	Transplantation 01/2014
1	Secondary Prevention 01/2010